The U.S. Drug and Enforcement Agency could hire informants to reveal where Mexican drug cartel tunnel "cover-ups" are located ...

Bella Vista "Friends of the Library" served with eviction notice from city ...

Dear [name of employee removed]: This Notice of Compliance with Conditions Qualifying Notice (NOC/c-QN), issued in accordance with the Health Canada Guidance Document: Notice of Compliance with ...

FDA provides comprehensive, AI-specific recommendations for handling cybersecurity threats, while also deferring to the 2023 Guidance for the complete framework that should be implemented prior to ...

The term notice of default refers to a public notice filed with a court that states that the borrower of a mortgage is in default on a loan. The lender may file a notice of default when a ...

On January 17, 2025, the FDA issued a notice in the Federal Register announcing a virtual public workshop entitled “Cell Therapies and Tissue-Based Products: A Public Workshop on Generating ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...